Zynex EV/EBITDA
¿Qué es el EV/EBITDA de Zynex?
El EV/EBITDA de Zynex, Inc. es 18.17
¿Cuál es la definición de EV/EBITDA?
EV / EBITDA es el valor de la empresa dividido por las ganancias antes de intereses, impuestos, depreciación y amortización. Es una medida de cuál cara es una acción y es más frecuentemente válida para comparaciones entre compañías que la relación precio / ganancias. Mide el precio (en forma de valor empresarial) que un inversionista paga en beneficio del flujo de caja de la compañía (en forma de EBITDA).
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV/EBITDA de compañías en Sector Health Care en XETRA en comparadas con Zynex
¿Qué hace Zynex?
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. It offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation (TENS), and neuromuscular electrical stimulation (NMES) device; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. The company also supplies electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products; and distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, and LSO Back Braces for lumbar support. In addition, it offers CM-1500, a blood volume monitor device for monitoring central blood volume for use in operating and recovery rooms to detect blood loss during surgery and internal bleeding during recovery. The company provides its products for use in pain management and control; and stroke and spinal cord injury rehabilitation. Zynex, Inc. sells its products through direct sales force primarily in the United States. The company was founded in 1996 and is headquartered in Englewood, Colorado.
Empresas con ev/ebitda similar a Zynex
- ZEAL Network SE tiene EV/EBITDA de 18.14
- Cello Health plc tiene EV/EBITDA de 18.15
- Lawson Products tiene EV/EBITDA de 18.15
- Public Service Enterprise tiene EV/EBITDA de 18.16
- Ordissimo SA tiene EV/EBITDA de 18.16
- G.S. Auto International tiene EV/EBITDA de 18.17
- Zynex tiene EV/EBITDA de 18.17
- American States Water Co tiene EV/EBITDA de 18.17
- Sanofi India tiene EV/EBITDA de 18.17
- Lennox International Inc tiene EV/EBITDA de 18.17
- Bajaj Finserv tiene EV/EBITDA de 18.17
- Bio-Rad Laboratories tiene EV/EBITDA de 18.17
- KUKA AG tiene EV/EBITDA de 18.17